Eagle Ridge Investment Management Abbott Laboratories Transaction History

Eagle Ridge Investment Management

$1.14 Billion
Q3 2024

A detailed history of Eagle Ridge Investment Management transactions in Abbott Laboratories stock. As of the latest transaction made, Eagle Ridge Investment Management holds 101,960 shares of ABT stock, worth $11.8 Million. This represents 1.02% of its overall portfolio holdings.

Number of Shares

101,960

Previous 101,839 0.12%

Holding current value

$11.8 Million

Previous $10.6 Million 9.85%

% of portfolio

1.02%

Previous 0.98%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$100.07 - $118.13 $12,108 - $14,293	121 Added 0.12%	101,960 $11.6 Million
Q2 2024 Jul 24, 2024	SELL	$100.73 - $112.44 $131,553 - $146,846	-1,306 Reduced 1.27%	101,839 $10.6 Million
Q1 2024 Apr 18, 2024	SELL	$109.52 - $120.96 $62,426 - $68,947	-570 Reduced 0.55%	103,145 $11.7 Million
Q4 2023 Feb 05, 2024	SELL	$90.19 - $110.4 $19,030 - $23,294	-211 Reduced 0.2%	103,715 $11.4 Million
Q3 2023 Oct 24, 2023	SELL	$95.53 - $114.62 $76,232 - $91,466	-798 Reduced 0.76%	103,926 $10.1 Million
Q2 2023 Jul 18, 2023	BUY	$100.78 - $112.29 $28,520 - $31,778	283 Added 0.27%	104,724 $11.4 Million
Q1 2023 Apr 18, 2023	SELL	$96.86 - $114.01 $40,390 - $47,542	-417 Reduced 0.4%	104,441 $10.6 Million
Q4 2022 Jan 19, 2023	SELL	$95.06 - $111.52 $128,140 - $150,328	-1,348 Reduced 1.27%	104,858 $0
Q3 2022 Oct 18, 2022	BUY	$96.76 - $112.03 $42,864 - $49,629	443 Added 0.42%	106,206 $10.3 Million
Q2 2022 Jul 19, 2022	BUY	$102.07 - $123.37 $124,219 - $150,141	1,217 Added 1.16%	105,763 $11.5 Million
Q1 2022 Apr 18, 2022	SELL	$114.02 - $139.04 $31,241 - $38,096	-274 Reduced 0.26%	104,546 $12.4 Million
Q4 2021 Jan 19, 2022	SELL	$115.53 - $141.46 $476,561 - $583,522	-4,125 Reduced 3.79%	104,820 $14.8 Million
Q3 2021 Nov 02, 2021	BUY	$116.66 - $129.06 $165,890 - $183,523	1,422 Added 1.32%	108,945 $12.9 Million
Q2 2021 Jul 19, 2021	SELL	$105.79 - $124.53 $233,690 - $275,086	-2,209 Reduced 2.01%	107,523 $12.5 Million
Q1 2021 Apr 19, 2021	SELL	$108.84 - $128.23 $3.46 Million - $4.07 Million	-31,776 Reduced 22.46%	109,732 $13.2 Million
Q4 2020 Jan 29, 2021	SELL	$105.0 - $114.42 $550,410 - $599,789	-5,242 Reduced 3.57%	141,508 $15.5 Million
Q3 2020 Oct 28, 2020	SELL	$91.64 - $111.29 $76,427 - $92,815	-834 Reduced 0.57%	146,750 $16 Million
Q2 2020 Jul 29, 2020	SELL	$76.57 - $98.0 $876,037 - $1.12 Million	-11,441 Reduced 7.19%	147,584 $13.5 Million
Q1 2020 Apr 29, 2020	SELL	$62.82 - $91.86 $699,437 - $1.02 Million	-11,134 Reduced 6.54%	159,025 $12.5 Million
Q4 2019 Feb 05, 2020	SELL	$78.51 - $87.4 $46,713 - $52,003	-595 Reduced 0.35%	170,159 $14.8 Million
Q3 2019 Oct 31, 2019	SELL	$81.84 - $88.74 $356,658 - $386,728	-4,358 Reduced 2.49%	170,754 $14.3 Million
Q2 2019 Aug 01, 2019	SELL	$72.88 - $85.0 $144,229 - $168,215	-1,979 Reduced 1.12%	175,112 $14.7 Million
Q1 2019 May 07, 2019	SELL	$66.22 - $80.06 $66,484 - $80,380	-1,004 Reduced 0.56%	177,091 $14.2 Million
Q4 2018 Feb 07, 2019	BUY	$65.56 - $74.27 $105,289 - $119,277	1,606 Added 0.91%	178,095 $12.9 Million
Q3 2018 Nov 09, 2018	SELL	$60.81 - $73.36 $129,342 - $156,036	-2,127 Reduced 1.19%	176,489 $12.9 Million
Q2 2018 Jul 26, 2018	SELL	$57.57 - $63.54 $159,641 - $176,196	-2,773 Reduced 1.53%	178,616 $10.9 Million
Q1 2018 Apr 25, 2018	SELL	$56.27 - $63.62 $195,988 - $221,588	-3,483 Reduced 1.88%	181,389 $10.9 Million
Q4 2017 Jan 26, 2018	SELL	$53.68 - $57.47 $669,872 - $717,168	-12,479 Reduced 6.32%	184,872 $10.6 Million
Q3 2017 Oct 26, 2017	BUY	$48.06 - $53.64 $9.48 Million - $10.6 Million	197,351	197,351 $10.5 Million

Others Institutions Holding ABT

# of Institutions

3,187

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Ridge Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Ridge Investment Management with notifications on news.

Account

Eagle Ridge Investment Management Abbott Laboratories Transaction History